to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Raising capital at any stage of a company's growth is challenging and requires creativity and tenacity. However, these hurdles are especially difficult to conquer at the earliest stages of an enterprise's development, the author says. This article discusses where and how to raise capital at the seed level and growth stages.
This legal expert provides ten tried and tested bootstrapping techniques.
Many entrepreneurs increasingly are exploring alternative ways to raise capital. This overview evaluates four of the most common alternative public equity tracks: foreign markets, corporate shells, private investment in a public equity, and direct public offerings.
Terry Bruggeman shares the tale of leading his life sciences company through the decision to obtain capital. After exploring the funding options, including VC and IPO, Bruggeman and his team decide to undertake a reverse merger.
Recounting the tale of founding and growing two companies, one which ultimately failed, the author argues that the key message about cash in a high growth business is raise more than you need, and spend less than you have.
This article will provide you with a starting point for understanding your financial statements. In it you will find guidelines for the type of information you need and suggestions on how to review it.
With only three quarters completed, 2013 has already been a record year for venture funding in digital health, according to San Francisco-based health IT incubator Rock Health, which has been tracking deals in the space since 2011.
Bringing new board members into your company can be complicated. Brad Feld provides some best practices for managing this complex process, including: recruiting, analyzing current board composition, and establishing selection criteria.
For entrepreneurs, the importance of cash flow cannot be overstated. Simply put, no cash, no business. Perhaps it's a good time to re-examine a few concepts about accounting and finance.
Regenerative medicine has come a long way in recent years, leading some venture capitalists to consider investing in it. The roadblock to investing in this field is not a lack of funds, but rather a lack of a clear explanation of regenerative medicine's commercial applications, says one former venture capitalist.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.